APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition.
Sarah NaguibEileen Ruth TorresChloe Lopez-LeeLi FanMaitreyee BhagwatKendra NormanSe-In LeeJingjie ZhuPearly YeMan Ying WongTark PatelSue-Ann MokWenjie LuoSubhash C SinhaMingrui ZhaoShiaoching GongLi GanPublished in: bioRxiv : the preprint server for biology (2024)
The R136S mutation on APOE3 enhances resistance to tau-related disease processes by downregulating the cGAS-STING-IFN signaling pathway.